BMBF Projects

Website: Project description of the BMBF
Topics: As part of the CLINSPECT-M joint project, a local research hub for investigating diseases of the nervous system was established in Munich during an initial funding phase. During this phase, new methods were developed for analysing spinal fluid and blood from patients and for examining tumour samples.
In the second funding phase, the methods developed will be used to identify biomarkers for various neurological diseases. The focus is on new biomarkers for Alzheimer's dementia, stroke, glioblastomas and chronic inflammation. The biomarkers will enable earlier diagnosis and better treatment of these diseases. To ensure a smooth transition to patient care, the two Munich university hospitals have been involved in the project from the outset.

Source: BMBF

BMBF/EU project: UNITE4TB - Academia and industry united innovation and treatment for tuberculosis
LMU Speaker: Prof. Dr. Michael Hölscher
Institution: Institute of Infectious Diseases and Tropical Medicine
Funding: 2021 to 2028

Website: UNITE4TB
Topics: Tuberculosis (TB) is one of the leading infectious causes of death worldwide. According to the World Health Organization, a total of 1.3 million people died from TB in 2022.
With 30 partners from 13 countries, UNITE4TB aims to set a new standard for anti-TB regimen development by upgrading the current clinical trial methodology and enhancing the efficiency with which new regimens are delivered. Following an overarching racetrack concept, the goal of the UNITE4TB Consortium is to deliver an efficient global clinical trials network equipped to implement phase 2 trials that conform to the highest regulatory standards.

Source: UNITE4TB

BMBF project: DIFUTURE
Speaker-LMU: Prof. Dr. Ulrich Mansmann
Institution: Institute of Medical Data Processing, Biometrics and Epidemiology (IBE)
Funding: 2018 to 2026

Website: Project description of the BMBF
Topics: The aim of the Federal Ministry of Education and Research's Medical Informatics Initiative is to make data from routine care available digitally, reliably and quickly for medical research. Through IT-supported analyses of this data, research helps to better identify and treat diseases and prevent them as effectively as possible. In the future, information on comparable medical cases or the results of current studies can also be made available to treating doctors. This information can then be used to make the best possible treatment decisions.

Source: BMBF